Rob is CEO of CURE Pharmaceutical, an innovative drug delivery company based in
Oxnard, California that is developing novel ways to deliver active ingredients,
including full spectrum hemp extract. Recognizing that hemp can offer a
sustainable solution to consumers and farmers, Davidson is focused on ensuring
industry development considers three autonomous constituents: social
development, economic development, and environmental safety.

Prior to his role at CURE Pharmaceutical, Robert Davidson served as President and
Chief Executive Officer of InnoZen Inc., Chief Executive Officer of Gel Tech LLC,
Chief Executive Officer of Bio Delivery Technologies Inc., and has served on
multiple corporate boards. Mr. Davidson was responsible for the development of
several drug delivery technologies and commercial brand extensions. He has
worked with brands such as Chloraseptic™, Suppress™, as well as Pediastrip™, a
private label electrolyte oral thin film sold in major drug store chains.

Rob received his B.S. degree with a concentration in Biological Life Sciences.
He holds a Masters Certificate in Applied Project Management from Villanova
University, a Masters of Public Health from American Military University, Virginia
and a Masters in Health and Wellness from Liberty University, Virginia. Davidson
also completed his Post Graduate Studies at the University of Cambridge with
letter of commendation.